MEMORIAL HERMANN TEXAS MEDICAL CNTR
1. Target Overview & Investment Thesis
MEMORIAL HERMANN TEXAS MEDICAL CNTR is a 1089-bed large academic medical center in HARRIS, TX with $2.64B in net patient revenue and a 2.8% operating margin. The hospital serves a payer mix of 11.2% Medicare, 6.4% Medicaid, and 82.4% commercial.
Thesis: Undervalued. Our ML models identify $194.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.8% to 10.2% (+736bps).
| Net Revenue HCRIS | $2.64B |
| Current EBITDA COMPUTED | $73.9M |
| Operating Margin COMPUTED | 2.8% |
| Occupancy HCRIS | 80.1% |
| Revenue / Bed COMPUTED | $2.4M |
| Net-to-Gross HCRIS | 25.2% |
| Distress Probability ML | 42.1% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 2.8% places it above the state median. Among 22 size-comparable peers (544-2178 beds), the median margin is -0.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (544-2178), prioritizing same-state peers. 22 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MEMORIAL HERMANN TEXAS MEDICAL (Target) | TX | 1089 | $2.64B | 2.8% |
| UT MD ANDERSON CANCER CENTER | TX | 721 | $4.90B | -0.8% |
| THE METHODIST HOSPITAL | TX | 966 | $2.63B | 5.2% |
| TEXAS CHILDRENS HOSPITAL | TX | 863 | $2.50B | -29.9% |
| METHODIST HOSPITAL | TX | 1729 | $2.42B | 22.9% |
| UT SOUTHWESTERN UNIVERSITY HOS | TX | 737 | $2.28B | -4.6% |
| MEMORIAL HERMANN HOSPITAL SYS | TX | 1417 | $2.15B | 7.3% |
| SCOTT AND WHITE MEMORIAL HOSPI | TX | 616 | $1.85B | -10.5% |
| MEDICAL CITY DALLAS | TX | 819 | $1.33B | 49.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $194.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $55.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $52.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $52.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $32.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.7M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $73.9M |
| + RCM Uplift | +$194.4M |
| Pro Forma EBITDA | $268.2M |
| Current Margin | 2.8% |
| Pro Forma Margin | 10.2% |
| WC Released (1x) | $101.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $113.6M | $2.43B | 21.39x | 84.5% |
| Base (11x exit) | 10.0x | 11.0x | $113.6M | $2.71B | 23.86x | 88.6% |
| Bull Case | 9.0x | 11.0x | $102.3M | $3.39B | 33.14x | 101.4% |
| Bull (12x exit) | 9.0x | 12.0x | $102.3M | $3.73B | 36.45x | 105.3% |
| Bear Case | 11.0x | 10.0x | $125.0M | $1.42B | 11.38x | 62.6% |
| Bear (11x exit) | 11.0x | 11.0x | $125.0M | $1.61B | 12.84x | 66.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 22 hospitals with 544-2178 beds
- Same-state prioritization (n=23)
- Comp margins: P25=-25.0% / P50=-0.2% / P75=11.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.